Univadis: Apps for Medical News, Medical Education, Medical Resources

HEPATITIS C CHANNEL

Stay ahead on Hepatitis C

Daily summaries of the best new literature
Free access to select articles from Journal of Hepatology, Gastroenterology and NEJM
A vast library of HCV guidelines

Explore the Hepatitis C Channel

ELEARNING NOW AVAILABLE

Access exclusive presentations from top medical experts

- Turn your limited free time into valuable learning experiences with concise video summaries by the experts
- Test your knowledge with weekly clinical cases
- Join your peers in the monthly image contest

Access presentations and cases

Medical News

The triple-drug regimen is now expected to be implemented in a number of countries including Papua New Guinea, Indonesia, India, Kenya and Zimbabwe.

Lymphatic filariasis: triple therapy tops single dose of two-drug combination

Univadis Medical News
14 November 2018

The triple-drug regimen is now expected to be implemented in a number of countries including Papua New Guinea, Indonesia, India, Kenya and Zimbabwe.

The results will help form the initial basis of a planned white paper on endocrinology.

Mapping endocrinology in Europe: views sought for survey

Univadis Medical News
14 November 2018

The results will help form the initial basis of a planned white paper on endocrinology.

The approach requires professionals in public health, animal health, plant health, food and the environment to work together.

One Health is only way to keep antibiotics working, say authorities

Univadis Medical News
14 November 2018

The approach requires professionals in public health, animal health, plant health, food and the environment to work together.

Promising results are being reported from a new international trial.

Phone app helps detect ST-segment elevation myocardial infarction

Univadis Medical News
14 November 2018

Promising results are being reported from a new international trial.

The study findings do not support scepticism towards vaccination motivated by allergy risk.

Study dismisses link between vaccines and allergy development in children

Univadis
14 November 2018

The study findings do not support scepticism towards vaccination motivated by allergy risk.

More Medical News >

Just Published

The algorithm developed for pulmonary fibrosis classification was assessed using a cohort of 150 high-resolution CT studies

Deep learning algorithm outperforms thoracic radiologists for classifying fibrotic lung disease

13 November 2018

The algorithm developed for pulmonary fibrosis classification was assessed using a cohort of 150 high-resolution CT studies

Researchers compared children with autism spectrum disorder using a previously validated machine learning algorithm

Increased extra-axial CSF: a potential marker in autism spectrum disorder?

The Lancet Psychiatry
12 November 2018

Researchers compared children with autism spectrum disorder using a previously validated machine learning algorithm

Study compare replication competence, tissue tropism, and host responses of influenza virus in ex-vivo human bronchus and human airway organoids

Human airway organoids for analysis of influenza virus pathogenesis and tropism

09 November 2018

Study compare replication competence, tissue tropism, and host responses of influenza virus in ex-vivo human bronchus and human airway organoids

Findings from a meta-analysis of 64 studies

Preservation of self-esteem in persecutory delusions: what does newer version of the psychological model suggest?

The Lancet Psychiatry
08 November 2018

Findings from a meta-analysis of 64 studies

Researchers measured microfilarial densities (MFDs) from 25 villages in Cameroon

Onchocerciasis and epilepsy: what’s the link?

07 November 2018

Researchers measured microfilarial densities (MFDs) from 25 villages in Cameroon

More Just Published >

The JAMA Network

Use of deep learning algorithms in medical image analysis

Deep learning helps to identify, classify, and quantify patterns in medical images

Global burden of firearm injury deaths

The study estimated firearm-related mortality from 1990-2016 for 195 countries and territories by age and by sex

Mild-to-moderate hypertension: does low-dose triple antihypertensive drug combination improve BP control vs usual care?

TRIUMPH: randomized open-label clinical trial among 700 hypertension patients enrolled from 11 urban hospital clinics in Sri Lanka

Screening of undiagnosed Afib through home-based wearable continuous ECG monitoring patch

mSToPS trial evaluated 2659 individuals at increased risk for Afib

Rhinoplasty: protection of augmented tip (PAT) flap technique to camouflage tip grafts

The PAT technique emphasizes to prevent tip irregularities and smooth infratip lobule transition in primary rhinoplasty

More The JAMA Network >

Conference Reports

HIV-Glasgow 2018 – Fostemsavir (BRIGHTE phase 3 study): 48-week subgroup analysis

Conference Reports
05 November 2018

Dr Peter Ackerman presented the recent results of the BRIGHTE study – an analysis of the prodrug fostemsavir as an attachment inhibitor against HIV. Metabolism to the active moiety temsavir is via the gastrointestinal tract and it has been designed specifically for HIV-1 infected heavily treatment-experienced patients (HTP) who are failing their current therapy. In the BRIGHTE study, 86% of patients coming into the trial had a prior history of AIDS.

HIV-Glasgow 2018 – HIV-associated tuberculosis: diagnosis, management, and prevention

Conference Reports
05 November 2018

Dr Graeme Meintjes presents an overview of diagnostic and prevention issues in adult patients with HIV-associated tuberculosis. Estimates for 2017 showed that approximately 10% of global TB cases occurred in HIV infected people. This group also displays a disproportionately high TB mortality rate. However, incidence rates of HIV-associated TB have declined over the last decade.

HIV-Glasgow 2018 – Ibalizumab phase 3 trial: week 25 and week 48 analysis

Conference Reports
05 November 2018

Dr Zvi Cohen presents the phase 3 trial results of ibalizumab in heavily treatment experienced adults with multidrug-resistant HIV-1 infection failing their current ARV regimen; ibalizumab was approved by the FDA in March 2018 for this patient population. Results from the Week 25 study (TMB-301) along with the Week 48 expanded access (completer) study (TMB-311) are discussed.

More Conference Reports >